LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.37
+3.03 (11.50%)
At close: May 12, 2025, 4:00 PM
29.37
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
LENZ Therapeutics Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for LENZ Therapeutics stock ranges from a low of $36 to a high of $51. The average price target of $41.8 forecasts a 42.32% increase in the stock price over the next year.
Price Target: $41.80 (+42.32%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +29.38% | May 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +2.15% | Apr 16, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $38 → $51 | Buy | Maintains | $38 → $51 | +73.65% | Apr 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $44 → $47 | Strong Buy | Maintains | $44 → $47 | +60.03% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +29.38% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
7.78M
Revenue Next Year
50.17M
from 7.78M
Increased by 544.90%
EPS This Year
-3.06
from -2.34
EPS Next Year
-2.89
from -3.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 11.9M | 59.6M | 147.0M |
| Avg | 7.8M | 50.2M | 126.4M |
| Low | 5.9M | 40.9M | 102.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 665.8% | 193.0% |
| Avg | - | 544.9% | 151.9% |
| Low | - | 425.3% | 105.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.65 | -2.22 | 0.17 |
| Avg | -3.06 | -2.89 | -0.86 |
| Low | -4.23 | -3.81 | -1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.